Parkinson’s disease: Production of dopamine neurons from stem cells steps closer

Stem cell therapies for brain disorders like Parkinson’s disease are rapidly moving toward clinical trials. However, before such treatments can leave the lab, it is vitally important to be able to consistently produce high-quality stem cells for transplant into patients. Now, scientists in Sweden have identified some insights – plus a set of markers – that should help control the quality of stem cells engineered for clinical use in Parkinson’s disease.

READ MORE:  http://bit.ly/2fAmW5E

Leave a reply